The Brain institute of America, LLC was formed in 2017 with the goal of developing biomarkers for brain diseases and brain cancer. Our goal is to develop effective biomarkers for those with chronic brain disorders including brain cancer. We specifically focus on noncoding RNAs, a type of molecule that operates by regulating gene function. We have identified several noncoding RNAs that are highly expressed in brain tissue, and we want to pursue those entities for biomarker development.